07C.71 :    Head & Neck

Purpose:  A research study to examine whether an investigational agent, Panitumumab, in combination with standard chemotherapy, is safe and effective in people with head and neck cancer.

Title:  A Randomized, Open-Label, Controlled, Phase II Trial of Combination Chemotherapy with or without Panitumumab as First-Line Treatment of Subjects with Metastatic or Recurrent Head and Neck Cancer, and Cross-Over-Second-Line Panitumumab Monotherapy of Subjects Who Fail the Combination Chemotherapy Only Arm (Amgen20050236). JOG 37

1 records found.